CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
12 hedge funds and large institutions have $4.96M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BL
1
BCWM LLC
Overland Park,
Kansas
|
$2.89M |
2 |
2
Jane Street
New York
|
$888K |
3 |
3
Citadel Advisors
Miami,
Florida
|
$257K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$24K |
5 |
5
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$305K |